US Patent

US10383834 — Reduced dose intravenous acetaminophen

Method of Use · Assigned to Mallinckrodt Hospital Products IP Unlimited Co · Expires 2028-11-13 · 2y remaining

Vulnerability score 75/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects a method for intravenous administration of acetaminophen at a single dose level of less than about 1000 mg for pain and/or fever treatment.

USPTO Abstract

Described herein are compositions and methods for intravenous administration of acetaminophen at a single dose level of less than about 1000 mg for the treatment or prevention of pain (e.g., postoperative pain) and/or fever.

Drugs covered by this patent

chembl-chembl112 (ACETAMINOPHEN)

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-2262`	—	chembl-chembl112

Patent Metadata

Patent number: US10383834
Jurisdiction: US
Classification: Method of Use
Expires: 2028-11-13
Drug substance claim: No
Drug product claim: No
Assignee: Mallinckrodt Hospital Products IP Unlimited Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.